Storia in 6 fonti

Sweeping job cuts at GSK to fund £400m Cambridge campus

GSK is poised to slash its back office headcount to help fund a £400m mega-campus in Cambridge in a move aimed a bolstering its pipeline.

Raccontata da

Confronto fonti

6 prospettive sulla stessa storia

AI · summaries

cityam.comStai leggendo13 h fa

Sweeping job cuts at GSK to fund £400m Cambridge campus

GSK is poised to slash its back office headcount to help fund a £400m mega-campus in Cambridge in a move aimed a bolstering its pipeline.

originale

Timeline cronologica

martedì 28 luglio 2026·biopharmadive.com
GSK prepares for patent cliff with $2.5B cost-cutting plan
The pharma hasn’t yet revealed what kind of job cuts might be involved in the plan, which will help it absorb the coming loss of patents important to its HIV drug franchise.
martedì 28 luglio 2026·independent.co.uk
GSK to shut Stevenage R&D hub under plans to open new site in Cambridge
The move will impact around 1,800 staff currently based in Stevenage.

theguardian.com

10 h fa

GSK to cut jobs amid £1.9bn cost-cutting plan and bid for faster drug development

Pharmaceuticals company is investing £400m in UK life sciences and moving scientists to new Cambridge R&D site

Leggi questa versione → originale

independent.co.uk11 h fa

GSK announces plans to close main research hub in Stevenage

Jump to contentThank you for registeringPlease refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged inAllNewsSportCultureLifestylePharmaceutical…

Leggi questa versione → originale

statnews.com9 h fa

GSK lays out plans to cut costs, pursue more late-stage drug trials

New GSK CEO Luke Miels outlined his strategy to help the company navigate a patent cliff and get on a path toward long-term growth.

Leggi questa versione → originale

biopharmadive.com1 g fa

GSK prepares for patent cliff with $2.5B cost-cutting plan

The pharma hasn’t yet revealed what kind of job cuts might be involved in the plan, which will help it absorb the coming loss of patents important to its HIV drug franchise.

Leggi questa versione → originale

fiercepharma.com10 h fa

GSK CEO targets $2.5B in cost savings from mature products, procurement, supply chain

About half a year into his tenure as GSK’s CEO, Luke Miels is launch | About half a year into his tenure as GSK’s CEO, Luke Miels is launching a three-year restructuring designed to generate $2.5 billion in annual cost…

Leggi questa versione → originale

martedì 28 luglio 2026·

cityam.com

Sweeping job cuts at GSK to fund £400m Cambridge campus

GSK is poised to slash its back office headcount to help fund a £400m mega-campus in Cambridge in a move aimed a bolstering its pipeline.

martedì 28 luglio 2026·

independent.co.uk

Pharma giant to relocate research hub to Cambridge in £400m move

GSK is hoping all workers will relocate to either Cambridge or Ware

martedì 28 luglio 2026·

independent.co.uk

GSK announces plans to close main research hub in Stevenage

Jump to contentThank you for registeringPlease refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged…

martedì 28 luglio 2026·

theguardian.com

GSK to cut jobs amid £1.9bn cost-cutting plan and bid for faster drug development

Pharmaceuticals company is investing £400m in UK life sciences and moving scientists to new Cambridge R&D site

martedì 28 luglio 2026·

fiercepharma.com

GSK CEO targets $2.5B in cost savings from mature products, procurement, supply chain

About half a year into his tenure as GSK’s CEO, Luke Miels is launch | About half a year into his tenure as GSK’s CEO, Luke Miels is launching a three-year restructuring designed…

martedì 28 luglio 2026·

statnews.com

GSK lays out plans to cut costs, pursue more late-stage drug trials

New GSK CEO Luke Miels outlined his strategy to help the company navigate a patent cliff and get on a path toward long-term growth.

Sweeping job cuts at GSK to fund £400m Cambridge campus

Timeline cronologica

GSK prepares for patent cliff with $2.5B cost-cutting plan

GSK to shut Stevenage R&D hub under plans to open new site in Cambridge

GSK to cut jobs amid £1.9bn cost-cutting plan and bid for faster drug development

GSK announces plans to close main research hub in Stevenage

GSK lays out plans to cut costs, pursue more late-stage drug trials

GSK prepares for patent cliff with $2.5B cost-cutting plan

GSK CEO targets $2.5B in cost savings from mature products, procurement, supply chain

Sweeping job cuts at GSK to fund £400m Cambridge campus

Pharma giant to relocate research hub to Cambridge in £400m move

GSK announces plans to close main research hub in Stevenage

GSK to cut jobs amid £1.9bn cost-cutting plan and bid for faster drug development

GSK CEO targets $2.5B in cost savings from mature products, procurement, supply chain

GSK lays out plans to cut costs, pursue more late-stage drug trials